ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980

Voluntary Organizations: ACS Board Approves Prostate Cancer Funding Set-Asides

November 15, 1996

NCI Awards Grants To Physicians For Cancer Detection

August 2, 1991

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985